Active Pharmaceutical Ingredient (API) Market by type (Innovative, generic), manufacturer (captive, merchant), synthesis (synthetic, biotech), by product (vaccines, Hormones), drug (OTC, Rx), application (Diabetes, oncology, CVD) - Global Forecast to 2025

Active Pharmaceutical Ingredient (API) Market by type (Innovative, generic), manufacturer (captive, merchant), synthesis (synthetic, biotech), by product (vaccines, Hormones), drug (OTC, Rx), application (Diabetes, oncology, CVD) - Global Forecast to 2025

The global active pharmaceutical ingredients market is projected to reach USD 248.3 billion by 2025 from USD 187.3 billion in 2020, at a CAGR of 5.8% during the forecast period. Growth in the active pharmaceutical ingredients market is primarily driven by factors such as growing use of immunoglobulins in various therapeutic areas, increase in plasma collection (and the number of plasma collection centers), rising geriatric population, and the growing prevalence of respiratory diseases and alpha-1-antitrypsin deficiency (AATD). However, the high cost of plasma products, limited reimbursements, and the emergence of recombinant alternatives are expected to restrain the growth of this market to a certain extent during the forecast period.

“Biotech APIs segment is expected to grow at the highest CAGR during the forecast period”
On the basis of type of synthesis, the APIs market is categorized into synthetic APIs and biotech APIs. The synthetic APIs segment is estimated to account for the largest share in 2019. However, the biotech APIs segment is expected to grow at a higher rate over the forecast period. Factors such as growing demand of biotech drugs due to their specificity in action, advancements in biotechnology, increase in the demand for monoclonal antibodies and their similarity with the natural biological compounds found in the human body influence the growth of this segment.

“Monoclonal antibodies segment is expected to account for the largest share of the global APIs market, by product type.”
Based on product, the biotech APIs market is segmented into monoclonal antibodies, hormones, cytokines, fusion proteins, therapeutic enzymes, vaccines and blood factors. In 2019, the monoclonal antibodies segment is estimated to account for the largest share of the APIs market. Large share of monoclonal antibodies is due to their rising application in oncology and other therapeutic areas, increase in number of FDA approvals for innovative biopharmaceutical products and increasing investments and technical advances in R&D for development of various novel products.

“North America will dominate the market during the forecast period.”
Geographically, the active pharmaceutical ingredients market is segmented into North America, Europe, Asia, andRest of the World. In 2019, North America accounted for the largest share of the active pharmaceutical ingredients market, followed by Europe and the Asia. The major factors driving the overall growth of the APIs market in this region include the growing prevalence of preventable chronic diseases, increasing government emphasis on generic drugs, escalating demand for biologics and specialty drugs, and technological advancements in the manufacturing processes of APIs.

The primary interviews conducted for this report can be categorized as follows:
By Company Type - Tier 1: 37%, Tier 2: 22%, and Tier 3: 41%
By Designation - C-level: 25%, D-level: 20%, and Others: 55%
By Region - North America: 40%, Europe: 27%, Asia: 20%, and RoW: 13%

List of Companies Profiled in the Report
Pfizer, Inc. (US)
Novartis Internationla AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (US)
GlaxoSmithKline plc (UK)
Merck & Co., Inc. (US)
Mylan N.V. (US)
AbbVie Inc. (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
AstraZeneca (UK)
Cipla, Inc. (India)
Dr. Reddy’s Laboratories Ltd. (India)
Sun Pharmaceutical Industries Ltd. (India)
API Pharma Tech (India)
BDR Pharmaceuticals Internationals Pvt. Ltd. (India)
Sreepathi Pharmaceuticals Limited (India)
Shilpa Medicare Limited (India)

Research Coverage:
This report provides a detailed picture of the global active pharmaceutical ingredients market. It aims at estimating the size and future growth potential of the market across different segments, such as type, type of manufacturer, type of synthesis, type of drug, application and region.. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total active pharmaceutical ingredients market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on active pharmaceutical ingredients offered by the top 25 players in the active pharmaceutical ingredients market. The report analyses the active pharmaceutical ingredients market based on the type, type of manufacturer, type of synthesis, type of drug, application and region..

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various active pharmaceutical ingredients across key geographic regions.


Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the active pharmaceutical ingredients market.

Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the active pharmaceutical ingredients market.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY SOURCES
      • PRIMARY SOURCES
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ESTIMATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET OVERVIEW
    • NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE & TYPE OF MANUFACTURER (2019)
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table INDICATIVE LIST OF DRUGS GOING GENERIC IN 2020
        • Table INDICATIVE LIST OF BIOLOGICS THAT GAINED REGULATORY APPROVAL IN THE US IN 2019
      • RESTRAINTS
      • OPPORTUNITIES
        • Table INDICATIVE LIST OF BIOSIMILARS THAT GAINED REGULATORY APPROVAL IN THE US (2019–2020)
      • CHALLENGES
    • IMPACT OF COVID-19 ON THE MARKET
      • Table INDICATIVE LIST OF COVID-19 THERAPEUTIC DRUGS IN THE PIPELINE (CLINICAL)
      • COVID-19 DRUG R&D: KEY DEVELOPMENTS
      • COVID-19 DRUG R&D: VACCINE PRODUCTION SCENARIO, BY COUNTRY
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM ANALYSIS OF THE PHARMACEUTICALS MARKET
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
    • INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS
      • GROWING NUMBER OF NEW MOLECULAR ENTITIES GAINING REGULATORY APPROVALS TO DRIVE MARKET GROWTH
        • Table INDICATIVE LIST OF BIOLOGICAL PRODUCTS THAT GAINED US FDA APPROVAL IN 2019
        • Table LIST OF MAJOR DRUGS SET TO LOSE PATENT PROTECTION IN 2020
        • Table INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
    • GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS
      • GOVERNMENT INITIATIVES SUPPORTING THE ADOPTION OF GENERIC DRUGS TO BOOST MARKET GROWTH
        • Table GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: GENERIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
    • CAPTIVE API MANUFACTURERS
      • HIGH MANUFACTURING FLEXIBILITY AND ASSURANCE OF PRODUCT QUALITY ARE THE KEY FACTORS SUPPORTING MARKET GROWTH
        • Table CAPTIVE API MANUFACTURERS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: CAPTIVE API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
    • MERCHANT API MANUFACTURERS
      • Table MERCHANT API MANUFACTURERS MARKET, BY REGION, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table EUROPE: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table ASIA: MERCHANT API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • MERCHANT API MANUFACTURERS MARKET, BY TYPE
        • Table MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table INNOVATIVE API MANUFACTURERS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: INNOVATIVE API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: INNOVATIVE API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: INNOVATIVE API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table GENERIC API MANUFACTURERS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: GENERIC API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: GENERIC API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: GENERIC API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS
        • Table MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS 2018–2025 (USD BILLION)
        • Table SYNTHETIC API MANUFACTURERS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: SYNTHETIC API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH API MANUFACTURERS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH API MANUFACTURERS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
    • SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS
      • Table SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table ASIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
        • Table SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: INNOVATIVE SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: GENERIC SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
    • BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS
      • Table TOP SELLING BIOLOGICS (2018)
      • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: INNOVATIVE BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table INDICATIVE LIST OF BIOSIMILARS THAT GAINED THE US FDA APPROVAL IN 2019
        • Table GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: GENERIC BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT 2018–2025 (USD BILLION)
        • Table INDICATIVE LIST OF MONOCLONAL ANTIBODIES THAT RECEIVED FDA APPROVAL IN 2019
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR HORMONES & GROWTH FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CYTOKINES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR FUSION PROTEINS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RECOMBINANT VACCINES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR THERAPEUTIC ENZYMES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR BLOOD FACTORS, BY COUNTRY, 2018–2025 (USD BILLION)
      • BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MAMMALIAN EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR MICROBIAL EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR YEAST EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR INSECT EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER EXPRESSION SYSTEMS, BY COUNTRY, 2018–2025 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
    • PRESCRIPTION DRUGS
      • GROWING DISEASE PREVALENCE IS EXPECTED TO DRIVE THE PRESCRIPTION DRUGS MARKET
        • Table PRESCRIPTION DRUGS MARKET, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: PRESCRIPTION DRUGS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
    • OVER-THE-COUNTER DRUGS
      • SALES OF OTC DRUGS HAVE RISEN DUE TO INNOVATIONS, PROMOTION OF SELF-MEDICATION, AND INCREASED ACCESS
        • Table OVER-THE-COUNTER DRUGS MARKET, BY REGION, 2018-2025 (USD BILLION)
        • Table NORTH AMERICA: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: OVER-THE-COUNTER DRUGS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
    • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY
      • LOW-TO-MODERATE-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
      • POTENT-TO-HIGHLY POTENT ACTIVE PHARMACEUTICAL INGREDIENTS
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
    • COMMUNICABLE DISEASES
      • INCREASING GLOBAL INCIDENCE OF COMMUNICABLE DISEASES TO DRIVE MARKET GROWTH
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR COMMUNICABLE DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
    • ONCOLOGY
      • INCREASING SPENDING ON CANCER MEDICATION TO SUPPORT THE GROWTH OF THIS SEGMENT
        • Table INDICATIVE LIST OF THE US FDA-APPROVED DRUGS FOR ONCOLOGY (2018)
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD BILLION)
    • DIABETES
      • HIGH GLOBAL PREVALENCE OF DIABETES TO DRIVE THE GROWTH OF THIS SEGMENT
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR DIABETES, BY COUNTRY, 2018–2025 (USD BILLION)
    • CARDIOVASCULAR DISEASES
      • GROWING INCIDENCE OF CARDIOVASCULAR DISEASES OWING TO SEDENTARY LIFESTYLES IS A MAJOR GROWTH DRIVER
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
    • PAIN MANAGEMENT
      • INCREASING DEMAND FOR INNOVATIVE AND ADVANCED PAIN MEDICATIONS IS A MAJOR GROWTH DRIVER FOR THIS MARKET
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR PAIN MANAGEMENT, BY COUNTRY, 2018–2025 (USD BILLION)
    • RESPIRATORY DISEASES
      • HIGH GLOBAL PREVALENCE OF RESPIRATORY DISEASES TO DRIVE THE GROWTH OF THIS SEGMENT
        • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2025 (USD BILLION)
        • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
        • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2018–2025 (USD BILLION)
    • OTHER THERAPEUTIC APPLICATIONS
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2018–2025 (USD BILLION)
  • ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION
    • INTRODUCTION
      • Table ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2018–2025 (USD BILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018– 2025 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
      • Table NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • US
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table US: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table US: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table US: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table US: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table US: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • CANADA
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table CANADA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table CANADA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table CANADA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table CANADA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
    • EUROPE
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
      • Table EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table EUROPE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
      • Table EUROPE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
      • Table EUROPE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
      • Table EUROPE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • GERMANY
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table GERMANY: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table GERMANY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table GERMANY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table GERMANY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table GERMANY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • FRANCE
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table FRANCE: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table FRANCE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table FRANCE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table FRANCE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table FRANCE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • UK
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table UK: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table UK: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table UK: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table UK: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table UK: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • ITALY
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ITALY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table ITALY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table ITALY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table ITALY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • SPAIN
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table SPAIN: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table SPAIN: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table SPAIN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table SPAIN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table SPAIN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • HUNGARY
        • Table HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table HUNGARY: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table HUNGARY: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table HUNGARY: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table HUNGARY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table HUNGARY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table HUNGARY: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table HUNGARY: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • REST OF EUROPE
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table ROE: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ROE: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table ROE: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table ROE: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table ROE: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
    • ASIA
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
      • Table ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table ASIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
      • Table ASIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
      • Table ASIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
      • Table ASIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • JAPAN
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table JAPAN: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table JAPAN: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table JAPAN: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table JAPAN: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025(USD BILLION)
        • Table JAPAN: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • CHINA
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table CHINA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table CHINA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table CHINA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table CHINA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • INDIA
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table INDIA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table INDIA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table INDIA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table INDIA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • SOUTH KOREA
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table SOUTH KOREA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • REST OF ASIA
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table ROA: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ROA: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table ROA: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table ROA: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table ROA: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
    • REST OF THE WORLD
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
      • Table ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table ROW: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
      • Table ROW: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
      • Table ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
      • Table ROW: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
      • Table ROW: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • ISRAEL
        • Table ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table ISRAEL: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ISRAEL: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table ISRAEL: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ISRAEL: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table ISRAEL: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table ISRAEL: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table ISRAEL: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
      • OTHER COUNTRIES
        • Table OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: MERCHANT API MANUFACTURERS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: MERCHANT API MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: SYNTHETIC ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: BIOTECH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY EXPRESSION SYSTEM, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF DRUG, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY POTENCY, 2018–2025 (USD BILLION)
        • Table OTHER COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION, 2018–2025 (USD BILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET EVALUATION FRAMEWORK
      • Table GROWTH STRATEGY MATRIX: EXPANSIONS AND COLLABORATIONS ARE THE WIDELY ADOPTED GROWTH STRATEGIES BY MARKET PLAYERS
    • COMPETITIVE SITUATION AND TRENDS
      • Table PRODUCT LAUNCHES, JANUARY 2017-AUGUST 2020
      • Table EXPANSIONS, JANUARY 2017-AUGUST 2020
      • Table ACQUISITIONS, JANUARY 2017-AUGUST 2020
      • Table AGREEMENTS, COLLABORATIONS, ALLIANCES, JOINT VENTURES, AND PARTNERSHIPS, JANUARY 2017-AUGUST 2020
  • COMPANY EVALUATION MATRIX AND COMPANY PROFILES
    • COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
    • COMPANY EVALUATION MATRIX
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • EMERGING COMPANIES
    • COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES
      • PROGRESSIVE COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
    • MARKET PLAYER RANKING
    • COMPANY PROFILES
      • PFIZER, INC.
      • NOVARTIS AG
      • SANOFI
      • BOEHRINGER INGELHEIM
      • BRISTOL-MYERS SQUIBB
      • TEVA PHARMACEUTICAL INDUSTRIES LTD.
      • ELI LILLY AND COMPANY
      • GLAXOSMITHKLINE PLC
      • MERCK & CO., INC.
      • MYLAN N.V.
      • ABBVIE INC.
      • F. HOFFMANN-LA ROCHE LTD.
      • ASTRAZENECA
      • DR. REDDY'S LABORATORIES LTD.
      • SUN PHARMACEUTICAL INDUSTRIES LTD.
      • CIPLA, INC.
      • API PHARMA TECH
      • BDR PHARMACEUTICALS INTERNATIONALS PVT. LTD.
      • SREEPATHI PHARMACEUTICALS LIMITED
      • SHILPA MEDICARE LIMITED
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook